Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.
about
Highlights on distinctive structural and functional properties of HTLV Tax proteinsComparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein.Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation.Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype.The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.HTLV-1 Tax mutants that do not induce G1 arrest are disabled in activating the anaphase promoting complex.Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax.Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathwaysHuman T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycleHuman T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitroHuman T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis.Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences.Human T-lymphotropic virus proteins and post-translational modification pathwaysComparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.Functional analysis of human T lymphotropic virus type 2 Tax proteins.Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution.PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivoUtilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition.
P2860
Q21131117-5312A5F2-2BFF-4BBC-BA07-FAB53F6BB048Q24653987-36C794D9-C4BD-4ECB-A275-02616A88D3FEQ24815719-5754C6B0-76F8-4779-A325-D7C562EEE2AFQ30353061-131BB3C1-8EBE-47AF-8D63-00C583F62E15Q34123855-A322E7EC-0DB1-490B-9811-9D7D83F1D2AAQ34326996-24DAD66A-8888-4283-B52E-C6A79D94CE27Q34387588-A20312EB-43DF-492D-B15F-AF3C63EDD19EQ35036496-3DFB4DC8-2FB6-4DDE-B950-90CEFCFA7799Q35104884-E19D747A-5F1E-4F51-912D-903AFF7D631BQ35261245-60738666-BFDB-4444-A643-E6A6B7B84441Q35635312-CB497082-363E-4BBD-9957-4A56CE5615B3Q35846944-A448ABE8-BA15-42A8-804A-776EE7AADEF0Q35909704-2FE0C528-8D0F-4DDD-937A-D96E31C5A49BQ36172168-7E0CBCDE-14E5-4337-9B47-EA914097289AQ36434903-5247103A-3D07-4FBB-82AA-3352964E4855Q36845774-090A0530-A8BB-4BD6-A5F0-7C6030CF0B5AQ36890778-15A7398C-94C3-47F5-996C-449BFCA1BAF5Q37352476-5D768EB4-CBC2-407E-9A9B-4B8D3D869C7EQ37511645-755E7EB3-AE08-4815-9CBE-8584F86CCFF8Q37945226-14AF2EF8-41A1-4304-9680-237B06AEA766Q38156859-32E62507-5378-4FC5-ABF3-F889FF192559Q39392791-0DFF72F6-B948-4116-887E-8C69CC300FFFQ40301664-B80D8B4A-1EE1-43B6-A036-96BC644F7C2BQ40492153-E006AB39-B73D-4BE8-A199-E63071F0CC29Q40532741-8719393A-0A77-4BA1-83C3-293222E5B0B2Q41895077-37D66CC3-A237-4D0A-8530-B3404A1CE575Q45637777-6D3E6FF4-4885-4044-9F62-A154D9EC516B
P2860
Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Differences in the ability of ...... 2 tax to inhibit p53 function.
@ast
Differences in the ability of ...... 2 tax to inhibit p53 function.
@en
type
label
Differences in the ability of ...... 2 tax to inhibit p53 function.
@ast
Differences in the ability of ...... 2 tax to inhibit p53 function.
@en
prefLabel
Differences in the ability of ...... 2 tax to inhibit p53 function.
@ast
Differences in the ability of ...... 2 tax to inhibit p53 function.
@en
P2093
P2860
P1433
P1476
Differences in the ability of ...... 2 tax to inhibit p53 function.
@en
P2093
C A Pise-Masison
L De Marchis
P F Lambert
P2860
P304
P356
10.1128/JVI.74.15.6866-6874.2000
P577
2000-08-01T00:00:00Z